rs28930368

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000939.4(POMC):​c.282C>T​(p.Ser94Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0186 in 1,556,648 control chromosomes in the GnomAD database, including 2,478 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 315 hom., cov: 33)
Exomes 𝑓: 0.018 ( 2163 hom. )

Consequence

POMC
NM_000939.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.10

Publications

7 publications found
Variant links:
Genes affected
POMC (HGNC:9201): (proopiomelanocortin) This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
POMC Gene-Disease associations (from GenCC):
  • obesity due to pro-opiomelanocortin deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • inherited obesity
    Inheritance: SD, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-25161603-G-A is Benign according to our data. Variant chr2-25161603-G-A is described in ClinVar as Benign. ClinVar VariationId is 335356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000939.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMC
NM_000939.4
MANE Select
c.282C>Tp.Ser94Ser
synonymous
Exon 3 of 3NP_000930.1
POMC
NM_001035256.3
c.282C>Tp.Ser94Ser
synonymous
Exon 4 of 4NP_001030333.1
POMC
NM_001319204.2
c.282C>Tp.Ser94Ser
synonymous
Exon 4 of 4NP_001306133.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMC
ENST00000395826.7
TSL:2 MANE Select
c.282C>Tp.Ser94Ser
synonymous
Exon 3 of 3ENSP00000379170.2
POMC
ENST00000405623.5
TSL:1
c.282C>Tp.Ser94Ser
synonymous
Exon 3 of 3ENSP00000384092.1
POMC
ENST00000264708.7
TSL:2
c.282C>Tp.Ser94Ser
synonymous
Exon 4 of 4ENSP00000264708.3

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3488
AN:
152064
Hom.:
315
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0276
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.309
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.0433
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.0282
GnomAD2 exomes
AF:
0.0524
AC:
8031
AN:
153260
AF XY:
0.0535
show subpopulations
Gnomad AFR exome
AF:
0.00267
Gnomad AMR exome
AF:
0.0422
Gnomad ASJ exome
AF:
0.00838
Gnomad EAS exome
AF:
0.327
Gnomad FIN exome
AF:
0.0448
Gnomad NFE exome
AF:
0.00297
Gnomad OTH exome
AF:
0.0240
GnomAD4 exome
AF:
0.0182
AC:
25513
AN:
1404470
Hom.:
2163
Cov.:
33
AF XY:
0.0201
AC XY:
13952
AN XY:
693614
show subpopulations
African (AFR)
AF:
0.00179
AC:
57
AN:
31886
American (AMR)
AF:
0.0396
AC:
1444
AN:
36492
Ashkenazi Jewish (ASJ)
AF:
0.00774
AC:
195
AN:
25206
East Asian (EAS)
AF:
0.293
AC:
10604
AN:
36176
South Asian (SAS)
AF:
0.0906
AC:
7255
AN:
80054
European-Finnish (FIN)
AF:
0.0439
AC:
2126
AN:
48410
Middle Eastern (MID)
AF:
0.00790
AC:
45
AN:
5698
European-Non Finnish (NFE)
AF:
0.00203
AC:
2197
AN:
1082344
Other (OTH)
AF:
0.0273
AC:
1590
AN:
58204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1446
2892
4339
5785
7231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3480
AN:
152178
Hom.:
315
Cov.:
33
AF XY:
0.0279
AC XY:
2076
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00275
AC:
114
AN:
41512
American (AMR)
AF:
0.0276
AC:
422
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3470
East Asian (EAS)
AF:
0.308
AC:
1591
AN:
5160
South Asian (SAS)
AF:
0.110
AC:
529
AN:
4816
European-Finnish (FIN)
AF:
0.0433
AC:
459
AN:
10610
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00426
AC:
290
AN:
67996
Other (OTH)
AF:
0.0275
AC:
58
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
141
282
422
563
704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00791
Hom.:
16
Bravo
AF:
0.0229
Asia WGS
AF:
0.165
AC:
572
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Obesity Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Obesity due to pro-opiomelanocortin deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.8
DANN
Benign
0.81
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28930368; hg19: chr2-25384472; COSMIC: COSV53034960; COSMIC: COSV53034960; API